Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps

Condition:   Nasal Polyps
Interventions:   Drug: Dupilumab SAR231893 (REGN668);   Drug: Placebo;   Drug: Mometasone furoate nasal spray
Sponsors:   Sanofi;   Regeneron Pharmaceuticals
Not yet recruiting – verified August 2016

View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

Leave a Reply

Your email address will not be published. Required fields are marked *